单位：[1]Graduate School, Beijing University of Chinese Medicine, Beijing, China[2]Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing, China
Capital's Funds for Health Improvement and Research; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81873396]; China-Japan Friendship Hospital
第一作者单位：[1]Graduate School, Beijing University of Chinese Medicine, Beijing, China
推荐引用方式(GB/T 7714)：
Zheng S-Y.,Cui H-J..Explore the efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients of different gender[J].ANNALS of ONCOLOGY.2020,31:S715-S715.doi:10.1016/j.annonc.2020.08.1161.
APA：
Zheng, S-Y.&Cui, H-J..(2020).Explore the efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients of different gender.ANNALS of ONCOLOGY,31,
MLA：
Zheng, S-Y.,et al."Explore the efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients of different gender".ANNALS of ONCOLOGY 31.(2020):S715-S715
医学